Skip to main content
. 2022 Jan 22;181(4):1575–1584. doi: 10.1007/s00431-021-04348-w

Table 2.

Characteristics and serum levels of zinc among patients with confirmed COVID-19 and control group

Patients with confirmed COVID-19 Control group p value
Patient number, n (%) 100 (100) 269 (100) -
Age, years (IQR) 13.3 (8–15.4) 10.1 (5.1–14.5) 0.006
Sex, n (%) 0.982
  Girl 56 (56) 151 (56.1)
  Boy 44 (44) 118 (43.9)
Serum zinc, median (IQR) (ng/mL) 88.5 (77.2–100) 98 (84–111) 0.001
Patient numbers according to serum levels of zinc, n (%) 0.623
Serum levels of zinc < 70 11 (11) 25 (9.3)
Serum levels of zinc > 70 89 (89) 244 (90.7)
Patient number according to months, n (%) <0.001 
August 35 (35) 119 (44.2)
September 31 (31) 61 (22.7)
October 21 (21) 88 (32.7)
November 13 (13) 1 (0.4)